Furthermore, several molecules, including human lipocalin-2, macrophage migration inhibitory factor, and CD163, have been identified as key regulators in the pathogenesis of AKI.[49,50] Macrophages also contribute to disease progression through the activation of signaling pathways such as nuclear factor-κB and retinoic acid signaling pathways.[16,51]. Here, CD163 is linked to acute kidney injury.